Suppr超能文献

预先使用已故供体进行肾移植是否能改善结局?来自法国移植网络的结果。

Does pre-emptive kidney transplantation with a deceased donor improve outcomes? Results from a French transplant network.

机构信息

Department of Nephrology, University Hospital Nancy, France.

出版信息

Transpl Int. 2011 Mar;24(3):266-75. doi: 10.1111/j.1432-2277.2010.01195.x. Epub 2010 Dec 14.

Abstract

Large analyses have demonstrated that pre-emptive kidney transplantation (PKT) leads to significant improvements in patient and graft survival when compared with transplantation performed after a period of dialysis. We analysed 1585 patients who received a first renal transplantation from a deceased donor between 2000 and 2004 in four French transplantation centres. The objective was to compare the characteristics of the deceased donor transplantations with or without previous dialysis and to evaluate the impact of PKT and length of dialysis on patient and graft outcomes. Mean age of recipients was 48.1 ± 13.4 years, 62% were men, and 118 (7.4%) of them received a pre-emptive transplantation. For the nonpre-emptive patients, mean time on pretransplant dialysis was 3.4 ± 3.2 years. Pretransplant factors independently related to pre-emptive transplantation were year of transplantation, centre and recipients characteristics: gender, diabetes history, blood group and donor age. Patients with pretransplant dialysis were three times more likely to have delayed graft function than pre-emptive transplant patients, and were 10 times more likely to receive post-transplant dialysis. Five-year patient survival was 92.9%. Five-year graft survival was 89.0%. Neither pre-emptive transplantation nor time on dialysis was significantly associated with patient and/or graft survival.

摘要

大量分析表明,与透析后进行移植相比,预先进行肾移植(PKT)可显著提高患者和移植物的存活率。我们分析了 2000 年至 2004 年间在法国四个移植中心接受首次尸肾移植的 1585 名患者。目的是比较有无透析史的已故供体移植的特征,并评估 PKT 和透析时间对患者和移植物结局的影响。受者的平均年龄为 48.1 ± 13.4 岁,62%为男性,其中 118 人(7.4%)接受了预防性移植。对于非预防性患者,移植前透析的平均时间为 3.4 ± 3.2 年。与预防性移植相关的独立移植前因素包括移植年份、中心和受者特征:性别、糖尿病史、血型和供体年龄。移植前有透析的患者发生延迟移植物功能的可能性是预防性移植患者的三倍,并且更有可能在移植后接受透析。5 年患者存活率为 92.9%。5 年移植物存活率为 89.0%。预防性移植或透析时间均与患者和/或移植物存活率无显著相关性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验